Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-22-079531
Filing Date
2022-12-13
Accepted
2022-12-13 16:35:41
Documents
2
Period of Report
2022-12-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1614
2 POWER OF ATTORNEY ea170023ex-24_hoththerape.htm EX-24 6602
  Complete submission text file 0001213900-22-079531.txt   9535
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Issuer) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address
Pavell Jeff (Reporting) CIK: 0001840601 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38803 | Film No.: 221460131